Sarcoidosis and the Heart: What Cardiologists Screen For When Other Organs Are Affected

Sarcoidosis is an inflammatory disease that most often affects the lungs and lymph nodes, but it can involve almost any organ—including the heart. When sarcoidosis impacts the heart (known as cardiac sarcoidosis), it can lead to serious issues like arrhythmias, conduction blocks, heart failure, and even sudden cardiac death. Early identification and monitoring by a cardiologist are key to preventing complications and guiding treatment.

Why Cardiologists Screen for Cardiac Sarcoidosis

Even if you've been diagnosed with sarcoidosis in the lungs, skin, or eyes, the heart may harbor silent inflammation. Cardiologists screen for cardiac sarcoidosis because:

• Heart involvement may be symptom-free until a serious event occurs.
• Early detection allows prompt treatment with medications (like corticosteroids) that can reduce inflammation and prevent scarring.
• Identifying conduction system disease or dangerous arrhythmias can guide decisions about pacemakers or defibrillators.
• Monitoring over time helps assess response to therapy and adjust treatment as needed.

Who Should Be Screened?

Not every person with sarcoidosis needs extensive cardiac testing, but certain factors raise the suspicion for heart involvement:

• Known sarcoidosis in two or more organ systems (e.g., lungs plus skin or eyes).
• Symptoms such as palpitations, lightheadedness, fainting, chest discomfort, or unexplained fatigue.
• Abnormal routine tests (e.g., resting ECG changes).
• Elevated biomarkers (brain natriuretic peptide [BNP] or troponin) suggesting strain or injury to the heart muscle.
• Family history of sudden cardiac death or cardiomyopathy.

If you fall into one or more of these categories, your cardiologist will likely recommend a tailored screening approach.

Key Screening Tools

Cardiologists use a combination of tests to uncover signs of cardiac sarcoidosis. Each offers unique information:

1. Resting Electrocardiogram (ECG)
   • Detects conduction delays (e.g., atrioventricular block), bundle branch blocks, or abnormal heart rhythms.
   • Quick, non-invasive, and widely available.
2. Ambulatory ECG Monitoring (Holter or Event Monitor)
   • Records your heart rhythm over 24–48 hours (Holter) or longer (event monitor).
   • Identifies intermittent arrhythmias like ventricular tachycardia or pauses that might be missed on a resting ECG.
3. Transthoracic Echocardiogram
   • Uses ultrasound to evaluate heart chamber sizes, wall motion, valve function, and ejection fraction.
   • May reveal areas of reduced movement or thinning/scarring of the heart muscle.
4. Cardiac Magnetic Resonance Imaging (MRI)
   • Visualizes inflammation (edema) and scarring (fibrosis) through specialized sequences.
   • Late gadolinium enhancement (LGE) pinpoints areas of permanent damage.
   • Helps distinguish sarcoidosis from other causes of cardiomyopathy.
5. Positron Emission Tomography (PET) Scan
   • Uses radiotracers (e.g., FDG) to detect active inflammation.
   • High uptake in focal areas suggests granulomatous activity.
   • Often paired with a low-carbohydrate diet beforehand to suppress normal heart muscle uptake.
6. Biomarker Testing
   • BNP or NT-proBNP levels can hint at heart strain or heart failure.
   • High-sensitivity troponin may rise with ongoing myocardial injury.
7. Endomyocardial Biopsy (in select cases)
   • Tissue sampling of heart muscle to look for noncaseating granulomas.
   • Limited sensitivity (patchy involvement) but highly specific when positive.
   • Reserved for cases where diagnosis remains uncertain despite imaging.

What Cardiologists Look For

During the evaluation, cardiologists focus on:

• Conduction System Disease
– Atrioventricular (AV) block (first-degree to complete heart block)
– Bundle branch blocks

• Arrhythmias
– Ventricular tachycardia or fibrillation (can lead to sudden cardiac arrest)
– Atrial arrhythmias (e.g., atrial fibrillation)

• Ventricular Dysfunction
– Reduced ejection fraction indicating impaired pumping ability
– Regional wall motion abnormalities

• Myocardial Inflammation and Scarring
– Active granulomas vs. permanent fibrosis
– Extent and location of involvement

• Risk Stratification
– Assessment of sudden death risk guides need for implanted cardioverter-defibrillator (ICD)
– Evaluation of heart failure symptoms and functional capacity

Treatment Implications

When cardiac sarcoidosis is confirmed or strongly suspected, treatment aims to reduce inflammation, preserve heart function, and prevent life-threatening events:

• Corticosteroids
– First-line therapy to suppress granulomatous inflammation
– Dosing and duration vary; cardiologists often coordinate with a sarcoidosis specialist

• Additional Immunosuppressive Agents
– Methotrexate, azathioprine, mycophenolate mofetil, or tumor necrosis factor (TNF) inhibitors
– Considered when steroids alone are insufficient or when minimizing steroid side effects

• Device Therapy
– Permanent pacemaker for significant AV block
– ICD for those at high risk of ventricular arrhythmias or sudden death
– Cardiac resynchronization therapy (CRT) for heart failure with dyssynchrony

• Heart Failure Management
– Standard medications (beta-blockers, ACE inhibitors/ARBs, diuretics)
– Lifestyle modifications: sodium restriction, fluid management, exercise as tolerated

• Close Follow-Up
– Repeat imaging (MRI/PET) to monitor treatment response
– Regular ECGs and Holter monitoring for ongoing rhythm assessment
– Lab tests for medication side effects and disease activity

Living Well with Cardiac Sarcoidosis

While a cardiac sarcoidosis diagnosis can feel overwhelming, many people lead active lives with proper management:

• Adhere to your medication regimen and follow-up schedule.
• Report new or worsening symptoms promptly: palpitations, dizziness, increased shortness of breath, or chest discomfort.
• Maintain a heart-healthy lifestyle: balanced diet, regular low-impact exercise, stress management, and smoking cessation.
• Stay informed—but avoid excess worrying. Knowledge and early intervention are your best tools.

Take the First Step: Symptom Checker

If you're experiencing unexplained symptoms like skin changes, fatigue, or respiratory issues alongside known cardiac concerns, use this free AI-powered tool to evaluate your symptoms for Sarcoidosis (Including Erythema Nodosum-Like Eruption) and better understand when to seek specialized care.

When to Speak to a Doctor

Always discuss any serious or life-threatening symptoms—such as fainting, severe chest pain, or new swelling of the legs—with a healthcare professional immediately. Even if tests are normal, ongoing monitoring ensures that cardiac sarcoidosis is caught early if it arises. Your cardiologist and sarcoidosis specialist will work together to tailor screening and treatment to your needs.

Staying proactive and engaged in your care can make a real difference. If you suspect cardiac involvement or have questions about sarcoidosis in any organ, speak to your doctor today.